When considering Interactive Response Technology (IRT), many think only about its base functionality – ensuring effective randomization and trial supply management (RTSM) while maintaining the blind during clinical trials. However, today, these critical functions have become a baseline for what the industry expects of this technology.
Since its inception over three decades ago, IRT has evolved to meet the ever-changing needs of the clinical development industry. Gone are the days of IRT only being used for basic RTSM functions in large, late-phase trials. Today, IRT is frequently relied on to:
- Support Phase I trials
- Accommodate all trial designs, including cohort and adaptive/platform trials
- Perform complex calculations and logic as per complex protocols
Clinical trial sponsors also expect more from the people behind their IRT solutions. A reliable IRT vendor should act as a partner and provide expert advice and guidance about the proper and efficient implementation of their IRT system. They should work to understand and analyze each study’s unique requirements and develop a strategy to meet the trial’s goals, identify and mitigate risks, and allow flexibility for the future.
Here we present specific examples of what an advanced IRT system and the people behind it can deliver, beyond the basic expectations of RTSM.